个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Expert Consensus on the Clinical Application of Thymosin Alpha 1 in Infectious Diseases and Critical Care Medicine

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ CSCD-C ◇ ESCI

作者：
Ke, Lu[1] * ; Li, Weiqin[1] ; Ning, Qin[2] ; Chen, Tao[2] ; Xie, Qing[3] ; Zhao, Yingren[4] ; Zhu, Yueyong[5] ; Wu, Xiaoping[6] ; Su, Zhijin[7] ; Sun, Shuilin[8] ; Zhao, Weifeng[9] ; Li, Jiabin[10] ; Lu, Hongzhou[11] ; Li, Xinwen[12] ; Wang, Kai[13] ; Dang, Shuangsuo[14] ; Li, Lanjuan[15,*1] ; Huang, Jianrong[15,*1] ; Yang, Yida[15] ; Lian, Jiangshan[15] ; Su, Junwei[15] ; Zhu, Biao[15] ; Hao, Shaorui[15] ; Guo, Yongzheng[15] ; Xiang, Dairong[15] ; Lang, Guanjing[15] ; Wang, Guiqiang[16] ; Gao, Zhiliang[17] ; Lin, Bingliang[17] ; Chen, Junfeng[17] ; Guan, Xiangdong[18] ; Wu, Jianfeng[18] ; Li, Jie[19] ; Li, Wu[20] ; Sheng, Guoping[21] ; Gao, Hainv[21] ; Zhang, Quan[22] ; Zhang, Wenhong[23] ; Jiang, Ronglin[24] ; Yao, Yongming[25] ; Zhang, Xijing[26] ; Xu, Lei[27] ; Liu, Jun[28] ; Li, Yongguo[29] ; Lin, Feng[30] ; Wu, Tao[30] ; Wei, Jia[31] ; Geng, Jiawei[32] ; Li, Shuchen[33] ; Wan, Hong[34] ; Li, Jun[35] ; Zhang, Liaoyun[36] ; Lu, Xiaobo[37] ; Lu, Mingqin[38] ; Yang, Yongfeng[39] ; Zhang, Liting[40] ; Ding, Xiangchun[41] ; Shang, Jia[42] ;
机构： [1]Gen Hosp Eastern Theater Command, Nanjing, Peoples R China [2]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China [3]Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai, Peoples R China [4]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China [5]Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China [6]Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China [7]Quanzhou First Hosp, Quanzhou, Fujian, Peoples R China [8]Nanchang Univ, Affiliated Hosp 2, Nanchang, Peoples R China [9]Suzhou Univ, Affiliated Hosp 1, Suzhou, Peoples R China [10]Anhui Med Univ, Affilated Hosp 1, Hefei, Peoples R China [11]Shenzhen Third Peoples Hosp, Shenzhen, Peoples R China [12]Shulan Ji Nan Hosp, Jinan, Peoples R China [13]Shandong Univ, Qilu Hosp, Jinan, Peoples R China [14]Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Peoples R China [15]Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China [16]Peking Univ First Hosp, Beijing, Peoples R China [17]Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Peoples R China [18]Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China [19]Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Med Sch, Nanjing, Peoples R China [20]Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China [21]Shulan Hangzhou Hosp, Hangzhou, Peoples R China [22]Guizhou Med Univ, Affiliated Hosp, Guiyang, Peoples R China [23]Fudan Univ, Huashan Hosp, Shanghai, Peoples R China [24]Zhejiang Prov Hosp Tradit Chinese Med, Hangzhou, Peoples R China [25]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 4, Beijing, Peoples R China [26]AF Med Univ, Xijing Hosp, Xian, Peoples R China [27]Tianjin Third Cent Hosp, Tianjin, Peoples R China [28]Suzhou Municipal Hosp, Suzhou, Peoples R China [29]Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China [30]Hainan Gen Hosp, Haikou, Peoples R China [31]Kunming Med Univ, Affiliated Hosp 2, Kunming, Peoples R China [32]First Peoples Hosp Yunnan Prov, Kunming, Peoples R China [33]Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China [34]2 Peoples Hosp Lanzhou, Lanzhou, Peoples R China [35]Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China [36]Shanxi Med Univ, Hosp 1, Taiyuan, Peoples R China [37]Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China [38]Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China [39]Second Hosp Nanjing, Nanjing, Peoples R China [40]Lanzhou Univ, Affiliated Hosp 1, Lanzhou, Peoples R China [41]Ningxia Med Univ, Affiliated Hosp 1, Yinchuan, Peoples R China [42]Henan Prov Peoples Hosp, Zhengzhou, Peoples R China
出处：
DOI： 10.1097/IM9.0000000000000176

关键词： thymosin alpha 1 infectious diseases critical illness clinical application consensus

摘要：
As immunotherapy gains increasing attention and clinical application, the immune modulation therapy has been widely used in the treatment of infectious and critical diseases. Clinical evidence has been accumulated for application of thymosin alpha 1 (T alpha 1), a classical immune modulator, in related domains. The National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases and other institutions invited multidisciplinary experts to develop this expert consensus on clinical application of T alpha 1 in infectious diseases and critical care medicine. Based on the latest domestic and international research findings and considering relevant factors, including economics, patient preferences and values, tradeoffs, accessibility, fairness and acceptability, the consensus assesses the quality levels of current evidence and forms 10 recommendations on the application of T alpha 1 in treatment of liver diseases, viral infections, bacterial infections and critical illnesses. This consensus aims to enhance understanding of T alpha 1 and improving its standardized application for clinicians.

基金：
the National Key Research and Development Program of China (2022YFC2304500) ;the National Science and Technology Major Project of China (2017ZX10203201).
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2025]版：
无
最新[2025]版：
大类 | 4 区 医学
小类 | 4 区 传染病学 4 区 微生物学
JCR分区：
出版当年[2024]版：
Q3 INFECTIOUS DISEASES Q4 MICROBIOLOGY
最新[2024]版：
Q3 INFECTIOUS DISEASES Q4 MICROBIOLOGY

影响因子： 最新[2024版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2023版]

第一作者：
第一作者机构： [1]Gen Hosp Eastern Theater Command, Nanjing, Peoples R China
通讯作者：
通讯机构： [15]Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China [*1]Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Infect Dis, Hangzhou 310003, Peoples R China
推荐引用方式(GB/T 7714)：
Ke Lu,Li Weiqin,Ning Qin,et al.Expert Consensus on the Clinical Application of Thymosin Alpha 1 in Infectious Diseases and Critical Care Medicine[J].INFECTIOUS MICROBES & DISEASES.2025,7(2):76-83.doi:10.1097/IM9.0000000000000176.
APA：
Ke, Lu,Li, Weiqin,Ning, Qin,Chen, Tao,Xie, Qing...&Shang, Jia.(2025).Expert Consensus on the Clinical Application of Thymosin Alpha 1 in Infectious Diseases and Critical Care Medicine.INFECTIOUS MICROBES & DISEASES,7,(2)
MLA：
Ke, Lu,et al."Expert Consensus on the Clinical Application of Thymosin Alpha 1 in Infectious Diseases and Critical Care Medicine".INFECTIOUS MICROBES & DISEASES 7..2(2025):76-83

相关文献

[1]Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: A randomized controlled study [2]Expert Consensus on the Clinical Application of Oral Small-molecule Antiviral Drugs Against COVID-19 [3]A randomized, controlled, clinical study of thymosin alpha-1 versus interferon-alpha in [corrected] patients with chronic hepatitis B lacking HBeAg in China [corrected]. [4]The roles of TNFAIP2 in cancers and infectious diseases [5]化疗联合胸腺肽α1治疗乳腺癌的基础与临床观察 [6]莱博雷生临床应用中国专家共识 [7]Enhancing infectious diseases early warning: A deep learning approach for influenza surveillance in China [8]胸腺肽α1对老年重症医院获得性肺炎患者免疫功能的影响 [9]Clinical Application of Microvolt-Level T-Wave Alternans [10]Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectious Diseases

资源点击量：98315 今日访问量：0 总访问量：858 更新日期：2025-10-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持：重庆聚合科技有限公司 地址：云南省昆明市西山区金碧路157号 ICP备案：滇ICP备15003244号